Education
About Us
Working with TipRanks
Follow Us
Hofseth Biocare ASA (GB:0Q6H)
:0Q6H
0Q6H Stock Chart & Stats
kr1.80
kr0.19(11.53%)
At close: 4:00 PM EST
kr1.80
kr0.19(11.53%)
Day’s Range― - ―
52-Week Rangekr1.61 - kr2.38
Previous CloseN/A
Volume1.25K
Average Volume (3M)333.00
Market Cap
kr781.05M
Enterprise Valuekr944.88M
Total Cash (Recent Filing)kr71.95M
Total Debt (Recent Filing)kr236.19M
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 07, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding395,081,020
10 Day Avg. Volume0
30 Day Avg. Volume333
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Hofseth Biocare ASA News
0Q6H FAQ
What was Hofseth Biocare ASA’s price range in the past 12 months?
Hofseth Biocare ASA lowest share price was kr1.60 and its highest was kr2.38 in the past 12 months.
What is Hofseth Biocare ASA’s market cap?
Hofseth Biocare ASA’s market cap is kr781.05M.
When is Hofseth Biocare ASA’s upcoming earnings report date?
Hofseth Biocare ASA’s upcoming earnings report date is Nov 07, 2025 which is today.
How were Hofseth Biocare ASA’s earnings last quarter?
Currently, no data Available
Is Hofseth Biocare ASA overvalued?
According to Wall Street analysts Hofseth Biocare ASA’s price is currently Overvalued.
Does Hofseth Biocare ASA pay dividends?
Hofseth Biocare ASA does not currently pay dividends.
What is Hofseth Biocare ASA’s EPS estimate?
Hofseth Biocare ASA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hofseth Biocare ASA have?
Hofseth Biocare ASA has 395,081,020 shares outstanding.
What happened to Hofseth Biocare ASA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Hofseth Biocare ASA?
Currently, no hedge funds are holding shares in GB:0Q6H
Company Description
Hofseth Biocare ASA
Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Technical Analysis
Hofseth Biocare ASA
―
―
Kali
―
Nutriband
―
BioNTech SE
―
RegenXBio
―
Fate Therapeutics
―
Options Prices
Currently, No data available
---